Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objectives of this study are: ● To compare the safety and tolerability of the to-be-marketed lopinavir/ritonavir tablet formulation with the marketed SGC formulation. ● To compare the safety, tolerability and antiviral activity of QD and BID dosing of the lopinavir/ritonavir tablet formulation.
Critère d'inclusion
- Infección por el virus de la Inmunodeficiencia Humana (VIH-1),HIV-1 infection